We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$704M
AUM Growth
-$442M
Cap. Flow
-$488M
Cap. Flow %
-69.26%
Top 10 Hldgs %
31.51%
Holding
402
New
6
Increased
57
Reduced
64
Closed
261

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$13.4M
2
TOL icon
Toll Brothers
TOL
+$11.4M
3
UNH icon
UnitedHealth
UNH
+$5.17M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.49M
5
SGRY icon
Surgery Partners
SGRY
+$2.55M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$21.1M
2
PODD icon
Insulet
PODD
+$19M
3
LOW icon
Lowe's Companies
LOW
+$16.2M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$15.8M
5
KEYS icon
Keysight
KEYS
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 32.95%
2 Consumer Discretionary 18.04%
3 Technology 14.64%
4 Financials 13.2%
5 Industrials 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
401
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-54,172
Closed -$5.91M
ATVI
402
DELISTED
Activision Blizzard
ATVI
– –
-2,873
Closed -$246K
13 14 15 16
17

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q2 2023 Portfolio in Review

As of Q2 2023, Lombard Odier Asset Management (Switzerland) held 402 positions worth $704M, down 39% from $1.15B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Lombard Odier Asset Management (Switzerland) withdrew a net $488M in Q2 2023, closing 261 positions and reducing 64 holdings. Its most notable exit was Insulet, an estimated $19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Lombard Odier Asset Management (Switzerland) opened a new position in ResMed worth $13.2M.

  • Lombard Odier Asset Management (Switzerland)'s largest Q2 2023 buy was ResMed: 60,254 shares worth $13.2M.
  • Lombard Odier Asset Management (Switzerland) added most to UnitedHealth in Q2 2023, an estimated $5.17M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q2 2023 reduction was DexCom, cutting an estimated $21.1M.
  • Lombard Odier Asset Management (Switzerland) fully exited Insulet in Q2 2023, selling an estimated $19M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 32% of its $704M portfolio in Q2 2023.
  • Lombard Odier Asset Management (Switzerland) opened 6 new positions and closed 261 in Q2 2023.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 39% quarter-over-quarter to $704M.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.